A comprehensive presentation on phospholipids including ,classification,functions ,lipid storage diseases, use of liposomes in cancer therapy ,detergents & their biochemical applications for undergraduate medical students & faculty .
presentations includes google images for lipid storage diseases & their diagnosis.
2. CLASSIFICATION OF PHOSPHOLIPIDS
⢠FATTY ACIDS +ALCOHOL+NITRGEN BASE+ PHOSPHARIC ACID
⢠I GLYCEROPHOSPHOLIPIDS ----OR PHOSPHOGLYCERIDE---GLYCEROL
/ALCOHOL
⢠II SPHINGOPHOSPHOLIPIDS----SPHINGOMYELINS----ALCOHOL â
SPHINGOSINE
3.
4.
5. GLYCEROPHOSPHOLIPIDS
⢠GLYCEROPHOSPHOLIPIDS---MAJOR LIPID IN BIOLOGICAL
MEMBRANE
⢠GLYCEROL -3-P IS esterified at C1& C2.
⢠C1---SATURATED FATTY ACID
⢠C2 ---UNSATURATED FATTY ACID
⢠TYPE â1âPHOSPHATIDIC ACID
⢠INTERMEDIADE IN SYNTHESIS OF TRIGLYCEROL
& PHOSPHOLIPIDS
6.
7. GLYCEROPHOSPHOLIPIDS
TYPE 2 âLECITHINâPHOSPOTIDYL CHOLINE
FATTY ACID +GLYCEROL )CHOLINE
⢠MOST ABUNDANT GROUP OF PHOSPHOLIPID IN CELL MEMBRANE
⢠PHOSPHATIDIC ACID + CHOLINE
⢠STORAGE OF BODYâCHOLINE (DONAR OF METHYL GROU IN METHYLATION
REACTIONS )
⢠CHOLINE âACETYL CHOLINE NERVE IMPULSE TRANSMISSION
⢠LYSOLECITHIN âREMOVAL OF FATTY ACIDS FROM C1 OR C2 OF
LECTHIN
DIPALMITOL LECITHIN âMAINTAIN SURFACE TENSIONâADHERENCE OF INNER
SURFACE OF LUNGS
DEFICIENCY âRESPIRATORY DISTRESS SYNDROME IN INFANTS
8.
9. GLYCEROPHOSPHOLIPIDS
TYPE III CEPHALIN ---(PHOSPHOTIDYL ETHANOLAMINE)
FATTY ACIDS +GLYCEROL +PHOSPHARIC ACID -ETHANOLAMINE(NITROGEN BASE )
⢠CLOTTING FACTOR III THROMBOPLASTIN âCEPHALIN
⢠FUNCTION HELPS IN CLOTTING OF BLOOD
TYPE IV PHOSPHOTIDYL INOSITOL
FATTY ACIDS +GLYCEROL +PHOSPHARIC ACIDâINOSITOL
SECONDARY MESSENGER FOR OXYTOCIN,VASSOPRESSIN
10. GLYCEROPHOSPHOLIPIDS
TYPE V PHOSPHTIDYL SERINE /PHOSPHOTIDYL THREONINE
⢠FATTY ACIDS +GLYCEROL +PHOSPHARIC ACID+SERINE
⢠FATTY ACIDS +GLYCEROL +PHOSPHARIC ACID+ THREONINE
⢠FOUND IN MOST TISSUES
TYPE VI PLASMALOGENS
⢠FATTY ACIDS LINKED WITH ETHER LINKAGE (NOT ESTER LINKAGE )
FUNCTIONS
⢠MYELIN SHEETH FORMATION
⢠CARDIAC MUSCLES
⢠PLATELET AGGREGATION
12. FUNCTIONS OF PHOSPHOLIPIDS
1. Along with structural component of membrane regulate membrane
permeability
2. ( lecithin /cephalin /cardiolipin )âpresent in electron transport
chain âassist in cell respiration
3. Amphipathic nature â combine with polar & nonpolar compounds
4 .absorption of fat from intestine
5.lipoprotein synthesis---lipid transport (LDL/VLDL/HDL)
6.PREVENT FATTY LIVERâREGARDED AS LIPOTROPIC FACTORS
7.SYNTHESIS OF PROSTAGLANDINS /PROSTCYCLINS /THROMBOXANES
PHOSPHOLIPIDSď ARACHIDONIC ACIDS-ď EICOSANOIDS
13.
14. FUNCTIONS OF PHOSPHOLIPIDS
9. REVERSE CHOLESTEROL TRANSPORT
⢠Eg LDL carrier of endogenous Cholesterol (LIVER TO PERIFERAL
TISSUE)
⢠VLDL carrier of endogenous TRIGLYCEROL (LIVER TO PERIFERAL
TISSUE)
10.SURFACTANT â(LOWERING SURFACE TENSION )âeg âDipalmitoyl
phosphatidyl choline âlung surfactant âdeficiency respiratory distress
syndrome
11.Singnal transmission across the membrane
12.Component of bile âemulsification of fat
21. LIPID STORAGE DISEASE
⢠GANGLIOSIDES -----COMPLEX GLYCOSPHINGOLIPIDS FOUND IN
GANGLIONS.
⢠THEY CONTAIN ONE OR MORE MOLECULES OF NANA (N acetyl
neuraminic acid) BOUND TO CERAMIDE OLIGO SACCHARRIDES.
⢠DEFECT IN DEGRDTION OF GANGLIOSIDES CAUSES
GANGLIOSIDOSIS----
⢠TAY SACHâ S DISEASE
26. Tay Sach disease: Inheritance
It is inherited as an autosomal recessive traits, with
a predilection in the Ashkenazi Jewish population,
where the carrier frequency is about 1/25.
27. Diagnosis of Tay-Sach disease
⢠is usually suspected in an infant with neurologic features and a cherry-red spot.
⢠Enzymatic Assays-Definitive diagnosis is by determination of the level of Ă-hexosaminidase A
in isolated blood leukocytes.
⢠Fine needle Aspiration Cytology of brain tissue â can show the degree of neuronal
degeneration. FNAC has a great potential for diagnosis and follow-up of Tay-Sachs disease
⢠Prenatal screening-Future at-risk pregnancies for both disorders can be monitored by
prenatal diagnosis by amniocentesis or chorionic villous sampling.
⢠Carrier screening- Identification of carriers within families is also possible by Ă-
hexosaminidase A and B determination.
29. LIPOSOMES
⢠SELECTIVE FUSION OF LIPOSOMES WITH TARGET CELLS â
CONTROLLING DRUG DELIVERY TO SPECIFIC CELLS âCANCER
TREATMENT
⢠REDUCE SIDE EFFECTS OF TOXIC DRUGS
⢠IMPROVE PHARMOCOKINETIC &PHARMACODYMICS OF DRUGS
30.
31. Detergents
I NATURAL a. Bile Salts &bile acids
Emulsification of fat in GIT
II SYNTHETIC
A. Anionic âSODIUM DODECYL SULPHATE (USED IN
ELECTROPHORESIS ANALYSIS )
PROTEIN +SDS = SOLUBILIZATION OF
PROTEINS(SO4 IMPARS NEGATIVE CHARGE ) ---
IMPARTS NEGATIVE CHARGE
B.CATIONIC ---CETYL TRIMETHYL AMMONIUM
BROMIDE (CTAB)
ANTIBACTERIAL AGENTS (HAND WASH CREAMS )
DESTROYING BACTERIAL MEMBRANE PROTEIN
CARRY POSITIVE CHARGE.